AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

ALFENTANIL

5 registrations across 3 African markets— 3 active

Markets with ALFENTANIL

🇲🇦Morocco
2 registrations
2 active
🇹🇳Tunisia
2 registrations
0 active
🇿🇦South Africa
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
RAPIFEN
Solution injectable / 1 mg (0.5mg/ml)
🇹🇳TunisiaPiramal Critical Care B.V.expiredNov 2021
RAPIFEN
Solution injectable / 1 mg/2ml
🇹🇳TunisiaJANSSEN-CILAGexpiredMar 1991
RAPIFEN 2 ml🇿🇦South AfricaPiramal Critical Care South Africa (Pty) LtdactiveJan 1900
RAPIFEN (H)
SOLUTION INJECTABLE
🇲🇦Morocco—active—
RAPIFEN (H)
SOLUTION INJECTABLE
🇲🇦Morocco—active—

ALFENTANIL in Africa — Regulatory Overview

ALFENTANIL is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 5 registrations, 3 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.